共 111 条
[1]
Khong JJ(2016)Risk factors for Graves’ orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) study J Clin Endocrinol Metab 101 2711-2720
[2]
Finch S(2017)Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management Expert Rev Ophthalmol 12 111-121
[3]
De Silva C(2022)Insights into current management strategies for dysthyroid optic neuropathy: a review Clin Ophthalmol 16 841-850
[4]
Blandford AD(2015)Prognosis and treatment of visual field defects Semin Neurol 35 549-556
[5]
Zhang D(2010)The correlation between visual acuity and color vision as an indicator of the cause of visual loss Am J Ophthalmol 149 1000-1004
[6]
Chundury RV(2021)Dysthyroid optic neuropathy: evaluation and management J Endocrinol Invest 44 421-429
[7]
Perry JD(1988)Optic nerve dysfunction in thyroid eye disease: CT Radiology 167 503-507
[8]
Tagami M(2021)Combination model of thyrotrophin receptor antibody and volumetric orbital apex crowding index as an indicator of dysthyroid optic neuropathy Dis Markers 2021 9964232-149
[9]
Honda S(2013)Superior ophthalmic vein enlargement and increased muscle index in dysthyroid optic neuropathy Ophthalmic Plast Reconstr Surg 29 147-564
[10]
Azumi A(2021)CT definition of the surgical apex in the orbit Sci Rep 11 11016-615